Inhibitory effect of bacteriocin-producing Lactobacillus brevis DF01 and Pediococcus acidilactici K10 isolated from kimchi on enteropathogenic bacterial adhesion

In vitro evaluation of probiotic properties of Lactobacillus acidophilus AD125 and antagonism against Escherichia coli O157:H7 adhesion to Caco-2 cell

“…The results showed competition was the main mode of action. 37,38 However, the study of Jiang et al found that displacement of Lactobacillus plantarum WLPL04 showed a higher reduction of adhesion of E. coli O157:H7 than the other two modes, 11 while exclusion of Lactobacillus brevis DF01 and Pediococcus acidilactici K10 played the main role for adhesion of E. coli O157:H7 in the study by Kim et al 14 These results indicate that the mode of antagonism varied, with individual differences between strains.…”

Isolation of the Cholesterol-Assimilating Strain Pediococcus acidilactici LRCC5307 and Production of Low-Cholesterol Butter

“…In a study by Song et al (2015) , various LAB species were isolated from kimchi , including P. acidilactici , in addition to various Lactobacillus sp. Moreover, Kim et al (2019) reported that P. acidilactici K10, isolated from kimchi , inhibited the adhesion of Salmonella typhimurium and Escherichia coli O157:H7, which are enteropathogenic bacteria, to HT-29 cells. Therefore, although P. acidilactici is not a major species among many LAB that are present in kimchi , it is thought that it can be isolated and has various functions.…”

Pediococcus acidilactici FZU106 alleviates high-fat diet-induced lipid metabolism disorder in association with the modulation of intestinal microbiota in hyperlipidemic rats

“…The present study indicated that dietary oral administration of P. acidilactici FZU106 effectively prevented HFD-induced hyperlipidemia, ameliorated liver metabolism function and intestinal microbiota composition. Mounting evidences suggest that intestinal microbes play an important role in the pathological development of hyperlipidemia and liver metabolism function ( Lv et al, 2019 ; Villanueva-Millán et al, 2015 ; Kim et al, 2019 ). In addition, previous study showed that intestinal flora is closely associated with lipid absorption in the intestine ( Martinez-Guryn et al, 2018 ).…”

“…Previous study indicated that the occurrence of hyperlipidemia is usually accompanied by the disorder of intestinal microbiota ( Villanueva-Millán et al, 2015 ). It is well known that probiotics regulate the ecological balance of intestinal microbiota and produce antibacterial substances (such as bacteriocins) and competing with pathogenic bacteria for adhesion and colonization in the intestine, so as to prevent or alleviate the occurrence of metabolic syndrome ( Kim et al, 2019 ). Among the commonly used probiotics, many strains belonging to Lactobacillus and Pediococcus have been preliminarily proved to have the effect of improving or intervening hyperlipidemia ( Chen et al, 2020a ; Oh et al, 2019 ; Lv et al, 2021 ).…”